Omkar Kawalekar: technology will unlock scalability and patient access

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/8e/18/68/8e1868dc-f19d-0a3b-5c97-f0aceede2b43/mza_15123957094614483735.jpg/600x600bb.jpg

Ori Spotlight

Ori Biotech

49 episodes

13 hours ago

Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

Life Sciences

Science

RSS

All content for Ori Spotlight is the property of Ori Biotech and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/14589339/14589339-1715686470337-417ca22a9cd8d.jpg

Omkar Kawalekar: technology will unlock scalability and patient access

Ori Spotlight

1 hour 8 minutes

1 year ago

Omkar Kawalekar: technology will unlock scalability and patient access

In this episode, Omkar Kawalekar of Deloitte's NextGenTherapies practice joins Ori CEO Jason C. Foster, to explore the significance of technology and strategic collaborations in overcoming manufacturing challenges and developing advanced therapies at scale. Their conversation covers key industry hurdles like supply chain optimization and the strategic planning necessary for bringing innovative treatments to market – offering insights into how the industry can achieve commercial viability and widespread patient access to CGTs. Learn more about Omkar: https://www.linkedin.com/in/omkar-kawalekar-7406887/